DISCOUNT OPTIONSSCHEIN - MODERNA Stock

Certificat

DE000VU1SXH5

Market Closed - Deutsche Boerse AG 01:51:50 2024-05-17 pm EDT
3.59 EUR 0.00% Intraday chart for DISCOUNT OPTIONSSCHEIN - MODERNA
Current month-2.45%
1 month-2.71%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 3.59 0.00%
24-05-16 3.59 -0.28%
24-05-15 3.6 -0.83%
24-05-14 3.63 0.00%
24-05-13 3.63 -1.09%

Delayed Quote Deutsche Boerse AG

Last update May 17, 2024 at 01:51 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying MODERNA, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU1SXH
ISINDE000VU1SXH5
Date issued 2023-01-05
Strike 200 $
Maturity 2024-06-21 (34 Days)
Parity 10 : 1
Emission price 1.99
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.71
Lowest since issue 2
Spread 0.01
Spread %0.28%

Company Profile

Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (95.7%) ; - revenues from grants (4%); - revenues from collaboration agreements (0.3%). At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development. Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Sector
-
More about the company

Ratings for Moderna, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Moderna, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
132.9 USD
Average target price
138.5 USD
Spread / Average Target
+4.22%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW